Product Code: TMRGL78460
The report provides revenue of the global liquid filled hard capsules market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global liquid filled hard capsules market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the liquid filled hard capsules market.
The report delves into the competitive landscape of the global liquid filled hard capsules market. Key players operating in the global liquid filled hard capsules market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global liquid filled hard capsules market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Liquid Filled Hard Capsules Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Size Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Liquid Filled Hard Capsules Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
- 4.5. Porter's Five Force Analysis
5. Key Insights
- 5.1. U.S. Dietary Supplements Regulatory Overview
- 5.2. Regulation of Dietary Supplements, by Country
- 5.3. Un-denatured Type II Collagen Analysis
- 5.4. Key Industry Events
- 5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Liquid Filled Hard Capsules Market Analysis and Forecast, by Size
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value & Volume Forecast, by Size, 2017-2031
- 6.3.1. Large Capsules
- 6.3.1.1. Size 000
- 6.3.1.2. Size 00 & 00E
- 6.3.2. Medium Capsules
- 6.3.2.1. Size 0 & 0E
- 6.3.2.2. Size 1
- 6.3.2.3. Size 2
- 6.3.3. Small Capsules
- 6.3.3.1. Size 3
- 6.3.3.2. Size 4
- 6.3.3.3. Size 5
- 6.4. Market Attractiveness Analysis, by Size
7. Global Liquid Filled Hard Capsules Market Analysis and Forecast, by Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value & Volume Forecast, by Application, 2017-2031
- 7.3.1. Drugs
- 7.3.2. Vitamins & Mineral
- 7.3.3. Amino Acids, Peptides, and Proteins
- 7.3.4. Lipids
- 7.3.5. Others
- 7.4. Market Attractiveness Analysis, by Application
8. Global Liquid Filled Hard Capsules Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value & Volume Forecast, by End-user, 2017-2031
- 8.3.1. Pharmaceutical & Biopharmaceutical Companies
- 8.3.2. Nutrition Supplement Manufacturers
- 8.3.3. Others
- 8.4. Market Attractiveness Analysis, by End-user/p>
9. Global Liquid Filled Hard Capsules Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value & Volume Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Liquid Filled Hard Capsules Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value & Volume Forecast, by Size, 2017-2031
- 10.2.1. Large Capsules
- 10.2.1.1. Size 000
- 10.2.1.2. Size 00 & 00E
- 10.2.2. Medium Capsules
- 10.2.2.1. Size 0 & 0E
- 10.2.2.2. Size 1
- 10.2.2.3. Size 2
- 10.2.3. Small Capsules
- 10.2.3.1. Size 3
- 10.2.3.2. Size 4
- 10.2.3.3. Size 5
- 10.3. Market Value & Volume Forecast, by Application, 2017-2031
- 10.3.1. Drugs
- 10.3.2. Vitamins & Mineral
- 10.3.3. Amino Acids, Peptides, and Proteins
- 10.3.4. Lipids
- 10.3.5. Others
- 10.4. Market Value & Volume Forecast, by End-user, 2017-2031
- 10.4.1. Pharmaceutical & Biopharmaceutical Companies
- 10.4.2. Nutrition Supplement Manufacturers
- 10.4.3. Others
- 10.5. Market Value & Volume Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. by Size
- 10.6.2. by Application
- 10.6.3. by End-user
- 10.6.4. by Country
11. Europe Liquid Filled Hard Capsules Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value & Volume Forecast, by Size, 2017-2031
- 11.2.1. Large Capsules
- 11.2.1.1. Size 000
- 11.2.1.2. Size 00 & 00E
- 11.2.2. Medium Capsules
- 11.2.2.1. Size 0 & 0E
- 11.2.2.2. Size 1
- 11.2.2.3. Size 2
- 11.2.3. Small Capsules
- 11.2.3.1. Size 3
- 11.2.3.2. Size 4
- 11.2.3.3. Size 5
- 11.3. Market Value & Volume Forecast, by Application, 2017-2031
- 11.3.1. Drugs
- 11.3.2. Vitamins & Mineral
- 11.3.3. Amino Acids, Peptides, and Proteins
- 11.3.4. Lipids
- 11.3.5. Others
- 11.4. Market Value & Volume Forecast, by End-user, 2017-2031
- 11.4.1. Pharmaceutical & Biopharmaceutical Companies
- 11.4.2. Nutrition Supplement Manufacturers
- 11.4.3. Others
- 11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. by Size
- 11.6.2. by Application
- 11.6.3. by End-user
- 11.6.4. by Country/Sub-region
12. Asia Liquid Filled Hard Capsules Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value & Volume Forecast, by Size, 2017-2031
- 12.2.1. Large Capsules
- 12.2.1.1. Size 000
- 12.2.1.2. Size 00 & 00E
- 12.2.2. Medium Capsules
- 12.2.2.1. Size 0 & 0E
- 12.2.2.2. Size 1
- 12.2.2.3. Size 2
- 12.2.3. Small Capsules
- 12.2.3.1. Size 3
- 12.2.3.2. Size 4
- 12.2.3.3. Size 5
- 12.3. Market Value & Volume Forecast, by Application, 2017-2031
- 12.3.1. Drugs
- 12.3.2. Vitamins & Mineral
- 12.3.3. Amino Acids, Peptides, and Proteins
- 12.3.4. Lipids
- 12.3.5. Others
- 12.4. Market Value & Volume Forecast, by End-user, 2017-2031
- 12.4.1. Pharmaceutical & Biopharmaceutical Companies
- 12.4.2. Nutrition Supplement Manufacturers
- 12.4.3. Others
- 12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. Japan
- 12.5.2. China
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia
- 12.6. Market Attractiveness Analysis
- 12.6.1. by Size
- 12.6.2. by Application
- 12.6.3. by End-user
- 12.6.4. by Country/Sub-region
13. Latin America Liquid Filled Hard Capsules Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value & Volume Forecast, by Size, 2017-2031
- 13.2.1. Large Capsules
- 13.2.1.1. Size 000
- 13.2.1.2. Size 00 & 00E
- 13.2.2. Medium Capsules
- 13.2.2.1. Size 0 & 0E
- 13.2.2.2. Size 1
- 13.2.2.3. Size 2
- 13.2.3. Small Capsules
- 13.2.3.1. Size 3
- 13.2.3.2. Size 4
- 13.2.3.3. Size 5
- 13.3. Market Value & Volume Forecast, by Application, 2017-2031
- 13.3.1. Drugs
- 13.3.2. Vitamins & Mineral
- 13.3.3. Amino Acids, Peptides, and Proteins
- 13.3.4. Lipids
- 13.3.5. Others
- 13.4. Market Value & Volume Forecast, by End-user, 2017-2031
- 13.4.1. Pharmaceutical & Biopharmaceutical Companies
- 13.4.2. Nutrition Supplement Manufacturers
- 13.4.3. Others
- 13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. by Size
- 13.6.2. by Application
- 13.6.3. by End-user
- 13.6.4. by Country/Sub-region
14. Middle East & Africa Liquid Filled Hard Capsules Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value & Volume Forecast, by Size, 2017-2031
- 14.2.1. Large Capsules
- 14.2.1.1. Size 000
- 14.2.1.2. Size 00 & 00E
- 14.2.2. Medium Capsules
- 14.2.2.1. Size 0 & 0E
- 14.2.2.2. Size 1
- 14.2.2.3. Size 2
- 14.2.3. Small Capsules
- 14.2.3.1. Size 3
- 14.2.3.2. Size 4
- 14.2.3.3. Size 5
- 14.3. Market Value & Volume Forecast, by Application, 2017-2031
- 14.3.1. Drugs
- 14.3.2. Vitamins & Mineral
- 14.3.3. Amino Acids, Peptides, and Proteins
- 14.3.4. Lipids
- 14.3.5. Others
- 14.4. Market Value & Volume Forecast, by End-user, 2017-2031
- 14.4.1. Pharmaceutical & Biopharmaceutical Companies
- 14.4.2. Nutrition Supplement Manufacturers
- 14.4.3. Others
- 14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. by Size
- 14.6.2. by Application
- 14.6.3. by End-user
- 14.6.4. by Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2021
- 15.3. Company Profiles
- 15.3.1. ACG
- 15.3.1.1. Company Description
- 15.3.1.2. Business Overview
- 15.3.1.3. Strategic Overview
- 15.3.1.4. SWOT Analysis
- 15.3.2. Altasciences
- 15.3.2.1. Company Description
- 15.3.2.2. Business Overview
- 15.3.2.3. Strategic Overview
- 15.3.2.4. SWOT Analysis
- 15.3.3. CapsCanada Corporation
- 15.3.3.1. Company Description
- 15.3.3.2. Business Overview
- 15.3.3.3. Strategic Overview
- 15.3.3.4. SWOT Analysis
- 15.3.4. Erawat Pharma Limited
- 15.3.4.1. Company Description
- 15.3.4.2. Business Overview
- 15.3.4.3. Strategic Overview
- 15.3.4.4. SWOT Analysis
- 15.3.5. Farmacapsulas S.A.
- 15.3.5.1. Company Description
- 15.3.5.2. Business Overview
- 15.3.5.3. Strategic Overview
- 15.3.5.4. SWOT Analysis
- 15.3.6. Fine USA Trading, Inc.
- 15.3.6.1. Company Description
- 15.3.6.2. Business Overview
- 15.3.6.3. Strategic Overview
- 15.3.6.4. SWOT Analysis
- 15.3.7. HealthCaps India Ltd.
- 15.3.7.1. Company Description
- 15.3.7.2. Business Overview
- 15.3.7.3. Strategic Overview
- 15.3.7.4. SWOT Analysis
- 15.3.8. Lefancaps
- 15.3.8.1. Company Description
- 15.3.8.2. Business Overview
- 15.3.8.3. Strategic Overview
- 15.3.8.4. SWOT Analysis
- 15.3.9. PLx Pharma, Inc.
- 15.3.9.1. Company Description
- 15.3.9.2. Financial Overview
- 15.3.9.3. Business Overview
- 15.3.9.4. Strategic Overview
- 15.3.9.5.SWOT Analysis
- 15.3.10. Lonza Group
- 15.3.10.1. Company Description
- 15.3.10.2. Financial Overview
- 15.3.10.3. Business Overview
- 15.3.10.4. Strategic Overview
- 15.3.10.5. SWOT Analysis
- 15.3.11. QUALICAPS
- 15.3.11.1. Company Description
- 15.3.11.2. Business Overview
- 15.3.11.3 .Strategic Overview
- 15.3.11.3. SWOT Analysis
- 15.3.12. Roxlor
- 15.3.12.1. Company Description
- 15.3.12.2. Business Overview
- 15.3.12.3. Strategic Overview
- 15.3.12.4. SWOT Analysis